Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG667705 Inhibitors

EG667705 inhibitors are a class of chemical compounds designed to interfere with specific cellular pathways, often targeting enzymatic activity involved in cellular signaling and regulation. The chemical structure of these inhibitors typically consists of heterocyclic core motifs, which enable selective binding to specific protein targets. These molecules can exhibit high affinity to their target sites, largely due to hydrogen bonding, hydrophobic interactions, and sometimes ionic interactions, which help stabilize their binding. The inhibitors may display a variety of functional groups that contribute to their binding specificity and potency, such as halogenated phenyl rings, amide linkages, and substituents that increase lipophilicity or improve pharmacokinetic properties. Additionally, the size and orientation of these chemical moieties can be crucial in allowing the inhibitors to occupy the active or allosteric sites of their molecular targets effectively.

The binding of EG667705 inhibitors to their target proteins often results in modulation of biochemical pathways, influencing downstream cellular processes. By inhibiting key enzymes or regulatory proteins, these compounds can alter the phosphorylation state of various signaling molecules or affect gene transcription, cellular growth, and apoptosis. Their high specificity often allows for significant selectivity between different cellular pathways, providing a unique ability to dissect complex biological processes. The chemical modifications in these inhibitors can be fine-tuned to enhance their activity or to improve their stability in different environments, such as varying pH or presence of metabolic enzymes. Structural variations can also influence their ability to penetrate cellular membranes, allowing them to be more or less effective in different cellular compartments. The precise mechanisms by which EG667705 inhibitors achieve their effects are often dependent on both their chemical structure and the specific biological context in which they are applied.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor that can prevent the activation of MAPK/ERK pathway, which may be involved in the regulation of Fam237b.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that can disrupt AKT signaling, potentially influencing pathways associated with Fam237b.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor that can suppress cell growth and proliferation signals, possibly affecting Fam237b expression.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor that potentially alters stress response pathways that might regulate Fam237b.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that can modulate stress and apoptotic pathways, potentially impacting Fam237b activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A PI3K inhibitor like LY294002, which can affect AKT signaling and thereby influence Fam237b.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

A ROCK inhibitor, which can modulate cytoskeletal dynamics and potentially affect cellular processes involving Fam237b.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

SRC family kinase inhibitor that can modulate various signaling pathways, possibly influencing Fam237b.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

A tyrosine kinase inhibitor that can affect cellular signaling and potentially impact pathways involving Fam237b.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

A RAF inhibitor that can affect the MAPK/ERK pathway, potentially modulating Fam237b activity.